MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    The role of genetics in patient selection and outcomes of deep brain stimulation in Parkinson’s disease

    K. Markopoulou, M. Farrer (Evanston, USA)

    Objective: Determine the role of genetic factors in selecting candidates for, and evaluating outcomes of, deep-brain stimulation (DBS) within the framework of the multi-national Genetic…
  • MDS Virtual Congress 2021

    Is there a place for virtual support groups for Parkinson’s disease in Africa? Lessons from the Covid-19 pandemic

    N. Fothergill-Misbah, J. Price, O. Thomas, J. Okeno, R. Walker, L. Ebenezer (Newcastle Upon Tyne, United Kingdom)

    Objective: Using a case study from Kenya to understand the potential role of virtual support groups for Parkinson’s disease (PD) in Africa. Background: The Covid-19…
  • MDS Virtual Congress 2021

    Spinal orthosis in antecollis and PISA syndrome in Parkinson.

    N. Batasuk, P. Ruthiraphong (Bangkok, Thailand)

    Objective: To demonstrate the efficacy of spinal orthosis in antecollis and PISA syndrome in Parkinson patients. Background: Postural deformities in Parkinson disease (PD) including antecollis,…
  • MDS Virtual Congress 2021

    Engage-PD: a Physical Activity Coaching Program via Telehealth for people with Parkinson’s Disease – Preliminary results a year after inception.

    C. Macpherson, M. King, H. Shih, J. Rieger, J. Fineman, J. Reid, A. Pacheco, H. Shah, R. Alcalay, L. Quinn (New York City, USA)

    Objective: The purpose of this study was to evaluate effects of a telehealth (TH) coaching program to promote physical activity (PA) in people with Parkinson’s…
  • MDS Virtual Congress 2021

    Overview of the population of patients with advanced Parkinson’s disease (aPD) initiating therapy with levodopa-carbidopa intestinal gel (LCIG): POMPE-PARK study on French health insurance data (2013-2017)

    JP. Azulay, D. Grabli, S. Benard, N. Kabore, MS. Behier (Marseille, France)

    Objective: To quantify the number of French aPD patients initiating continuous delivery of LCIG from 2013 to 2017 and to describe their demographic, clinical and…
  • MDS Virtual Congress 2021

    PREVALENCE OF MOVEMENT DISORDERS AT A TERTIARY HEALTH CARE CENTRE IN ABUJA, NIGERIA

    N. Obianozie, G. Onwuegbuzie, P. Alabi, F. Abdulai (Gwagwalada, Nigeria)

    Objective: This study aims to describe the prevalence and sociodemographic characteristics of movement disorders seen at our Specialised Movement Disorder (MD) clinic at Abuja, Nigeria…
  • MDS Virtual Congress 2021

    Experiences of home-based dance participation in people with Parkinson’s

    J. Bek, M. Groves, D. Leventhal, E. Poliakoff (Manchester, United Kingdom)

    Objective: To investigate experiences of people with PD in using digital resources for home-based dance participation during the COVID-19 pandemic. Background: Dance is associated with…
  • MDS Virtual Congress 2021

    An International Pre-Implementation Survey To Assess The Acceptability Of Telemedicine As An Alternative To In-Person Clinic Consultations For PD

    O. Ojo, JH. Ahn, Z. Aldaajani, J. Bajwa, A. Bustillo, A. Cardozo, M. Dekker, E. Eldayem, Z. Mari, A. Shalash, M. Shackleford, M. Spindler, J. Youn, E. Cubo, N. Okubadejo (Idi-Araba, Nigeria)

    Objective: To assess the acceptability of virtual consultations as an option for out-patient clinic consultations for PD Background: The practice of telemedicine increased dramatically on…
  • MDS Virtual Congress 2021

    The OASIS (OpicApone in Sleep dISorder) study in Parkinson’s disease: design and rationale of an open-label, single-arm, pilot trial

    R. Costa, C. Trenkwalder, J. Ferreira, D. Magalhães, J. Rocha, P. Soares-da-Silva (Coronado, Portugal)

    Objective: To evaluate the effects of opicapone (OPC) treatment on sleep disorders in patients with Parkinson’s disease (PD) and ‘wearing-off’. Background: OPC proved to be…
  • MDS Virtual Congress 2021

    LRRK2 Inhibition by BIIB122 / DNL151: Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics in Ph 1 Healthy Volunteer and Ph 1B Parkinson’s Disease Trials

    D. Jennings, J. Wetering Derooij, M. Vissers, J. Heuberger, G. Groeneveld, R. Macuica, A. Kay, M. Borin, B. Wong, V. Daryani, S. Huntwork-Rodriguez, P. Chin, C. Ho, M. Troyer (South San Francisco, USA)

    Objective: To evaluate safety, tolerability, pharmacokinetics (PK), and pharmacodynamics of the LRRK2 inhibitor, DNL151 (BIIB122), in healthy volunteers (HVs) and Parkinson’s disease (PD) patients. Background:…
  • « Previous Page
  • 1
  • …
  • 384
  • 385
  • 386
  • 387
  • 388
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley